ARCHIVES

DCT Board Okay Recompetitions, Delays Decision On Clonogenic Assays

This article is from The Cancer Letter archive.

Vol. 09 No. 25 | June 24, 1983

Download PDF Visit The Full Archive

Related Articles

Russian-American Breast Cancer Meeting Canceled

April 14, 1995

Guest Editorial By ACS Chief Medical Officer Otis Brawley: ACS Revises Process for Making Guidelines

January 13, 2012

In Brief: Ford Named Acting Deputy Director, DCPC; Foundation Leads Oncology Administrators

June 3, 1994

DeVita’s Appointment Reportedly On Carter’s Desk, May Be Made Official By End Of Month

May 9, 1980

Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival

April 27, 2012

Et2’s Referral Guidelines

July 23, 1993